Scintigraphy for transthyretin cardiac amyloidosis diagnosis in Austria, Germany, and Switzerland from 2021 to 2024. A survey report.

Eur J Nucl Med Mol Imaging · 2026 · PMC12830428 · PMID 41037105

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Conclusion The results of nuclear medicine imaging for cardiac amyloidosis in the three European countries Austria, Germany, and Switzerland in 2021 and 2024 reveal an increasing trend in diagnosis.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.